Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells

By Mehta R.R.   Hawthorne M.E.   Graves J.M.   Mehta R.G.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 902-907

Elsevier

Access to resources Recommend Favorite

Human transplacental passage of the retinoid fenretinide (4HPR)

By Formelli F.   De Palo G.   Costa A.   Veronesi U.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 428-429

Elsevier

Access to resources Recommend Favorite

Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide

By Dietze E.C.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the combination of vitamin K and teriparatide on the bone metabolism in ovariectomized rats

By              

Biomedical Reports, Vol. 3, Iss. 3, 2015-01 ,pp. : 295-300

Science Publishers

Access to resources Recommend Favorite

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

By Shaker Mohammad   Yang Guang   Timme Terry   Park Sang   Kadmon Dov   Ren Chengzhen   Ji Xiaorong   Lee Hon-Man   Sehgal Inder   Anzano Mario   Sporn Michael   Thompson Timothy  

Clinical and Experimental Metastasis, Vol. 18, Iss. 5, 2000-09 ,pp. : 429-438

Springer Publishing Company

Access to resources Recommend Favorite